search
Back to results

Comparing Expulsion Rates for Different Intrauterine Device Insertion Techniques

Primary Purpose

IUD Insertion Complication, IUD; Complications, Infection or Inflammation

Status
Unknown status
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
IUD
Sponsored by
Kasr El Aini Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for IUD Insertion Complication focused on measuring IUD expulsion, hang up technique, postpartum insertion

Eligibility Criteria

22 Years - 40 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Full term patients (≥ 37 weeks gestation).
  • Singleton pregnancy.
  • Elective cesarean section for an uncomplicated pregnancy.
  • Healthy uterine cavity (no fibroid and no congenital anomaly) (Previously documented by history taking and/or ultrasound before pregnancy, and to be re-confirmed intraoperative).

Exclusion Criteria:

  • Preterm labor.
  • Uterine fibroid distorting uterine cavity.
  • History suggestive of previous pelvic inflammatory disease (Fever due to vaginal infection, ovarian abscess, repeated offensive vaginal infection, hydro/pyo-salpinx) 2
  • Rupture of membrane more than 12 hours.
  • Multi-fetal pregnancy
  • Placenta previa.
  • Previous uterine surgery other than CS
  • Documented congenital uterine anomalies intraoperative.
  • History of IUD insertion before this pregnancy with side effects like "bleeding, ectopic pregnancy, expulsion, pelvic inflammatory disease"
  • Uterine atony after delivery.

Sites / Locations

  • obstetrics and gynecology department, Kasr Alainy hospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Active Comparator

Active Comparator

Arm Label

Hang up technique

Postpartum insertion

Control

Arm Description

where the enrolled patients will have the IUD applied in the middle of the uterine cavity and then attached to the fundus of the uterus by an absorbable suture "Hang up technique"

will include patients where IUD will be inserted after 6 weeks post-partum.

will serve as our control group where the enrolled patients will have the IUD just applied into the middle of the uterine cavity at the level of the fundus without attachment

Outcomes

Primary Outcome Measures

Expulsion rates
IUD expulsion among the 3 groups at different intervals 24hours, 6 weeks, 3 and 6months postpartum

Secondary Outcome Measures

Temperature
postpartum fever (38 degrees celsius or above)
Irregular bleeding
defined as irregular bleeding and menorrhagia discovered at 6 weeks, 3 and 6months postpartum
Vaginitis
Defined as smelly odor, discharge diagnosed at 6 weeks, 3 and 6months postpartum
postpartum hemorrhage
Defined as heavy bleeding after delivery diagnosed in the first 24 hours after labor

Full Information

First Posted
October 16, 2018
Last Updated
December 2, 2018
Sponsor
Kasr El Aini Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT03724708
Brief Title
Comparing Expulsion Rates for Different Intrauterine Device Insertion Techniques
Official Title
Comparing Expulsion Rates When Using "Hang Up" Intrauterine Device Insertion Technique to Postplacental and Postpartum Insertion
Study Type
Interventional

2. Study Status

Record Verification Date
December 2018
Overall Recruitment Status
Unknown status
Study Start Date
December 2, 2018 (Actual)
Primary Completion Date
August 2019 (Anticipated)
Study Completion Date
September 2019 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Kasr El Aini Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
the investigators are trying to determine if this method of intrauterine device (IUD) insertion "hang up technique" has less expulsion rates than 6 week insertion or immediate post-placental insertion.
Detailed Description
This prospective multi-center clinical trial will be conducted at the Kasr Alainy maternity hospital, and AL-Zahra university hospital after approval from both ethics committees was obtained (OBGYN Scientific & ethics committee and Al-Zahra ethics committee). The study will enroll pregnant women attending the antenatal care clinic who have been scheduled for elective cesarean section after obtaining a signed informed consent from all participants. The enrolled participants will be divided into 3 groups: Group A: will serve as our experimental group where the enrolled patients will have the IUD applied in the middle of the uterine cavity and then attached to the fundus of the uterus by an absorbable suture "Hang up technique" (Tjahjanto & Haryuni, 2014) Group B: will serve as our active comparator and will include patients where IUD will be inserted after 6 weeks post-partum. Group C: will serve as our control group where the enrolled patients will have the IUD just applied into the middle of the uterine cavity at the level of the fundus without attachment. Randomization will be done by a computer-generated randomization table, and assignment into the various groups will be done by a sealed opaque envelope system which will be opened by the circulating nurse in the operating room during cesarean section. In both groups A and C, a Copper T-380 IUD (TCU 380 A with safe load PREGNA INTERNATIONAL LTD® manufactured by PREGNA® - India) was placed in the middle of the uterine cavity, and the threads was passed through the cervix after dilatation by one finger. In group (A) Hang up technique will be done with the same technique of a previous study done by Tjahjanto and Haryuni in 2014, but by using 2-0 Polyglactin 910 undyed braided absorbable suture with a straight needle "KS 60mm reverse cutting" (VICRYL RAPIDE™ ETHICON®). The needle will be inserted perpendicularly from the outside the uterus to penetrate the median of the fundus wall to get into the uterine cavity. Once the surgical thread entered the uterine cavity, the needle is clamped with rings forceps and pulled out through the lower uterine segment incision. Subsequently, an anchor knot is made on the crossing arm so that the IUD is balanced and hanging flexibly on the wall of the fundus. The IUD string is then cut in the middle of the long thread. Using ring forceps for clamping the IUD, it is inserted into the uterine cavity while simultaneously pulling the surgical thread out of the uterus so that the IUDs horizontal arm is touching the uterine fundus. The position of IUD remains suspended by the thread. Then, a knot is made on the outer surface of the uterus so the IUD will be fixed and hangs from the fundus (Tjahjanto & Haryuni, 2014) The patients will be evaluated for postpartum hemorrhage and fever 24 hours following the surgery. Patients will be re-evaluated 6 weeks, 3 and 6months postpartum for vaginal bleeding (irregular bleeding and menorrhagia), vaginitis (smelly odor, discharge) PID (fever, ovarian abscess, hydro/pyo-salpinx). Patients will also be re- evaluated by trans-vaginal ultrasound (US) to assess the position of IUD inside uterine cavity at 24hours, also at 6 weeks, 3and 6 months post-operative. Expulsion is defined when the IUD is not seen inside the uterine cavity by US and fundal displacement is noted when distance between transverse limb of IUD and fundus more than 20mm. If the acceptor does not arrive on time, they will be invoked by a call. If they cannot be contacted or found until the end of the study they will be considered as loss of follow-up. sample size: the investigators are planning a study of independent cases and controls with 1 control(s) per case. Prior data indicate that the probability of exposure among controls is 0.044. If the true probability of exposure among cases is 0. 24 (Chen et al, 2010). We will need to study 49 case patients and 49 control patients to be able to reject the null hypothesis that the exposure rates for case and controls are equal with probability (power) 0.8. The Type I error probability associated with this test of this null hypothesis is 0.05. we will increase the number of participants to 54 in each group (10%) to allow for drop outs.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
IUD Insertion Complication, IUD; Complications, Infection or Inflammation
Keywords
IUD expulsion, hang up technique, postpartum insertion

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
randomized controlled trial
Masking
Participant
Masking Description
randomised computer generated table and closed envelope system
Allocation
Randomized
Enrollment
162 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Hang up technique
Arm Type
Experimental
Arm Description
where the enrolled patients will have the IUD applied in the middle of the uterine cavity and then attached to the fundus of the uterus by an absorbable suture "Hang up technique"
Arm Title
Postpartum insertion
Arm Type
Active Comparator
Arm Description
will include patients where IUD will be inserted after 6 weeks post-partum.
Arm Title
Control
Arm Type
Active Comparator
Arm Description
will serve as our control group where the enrolled patients will have the IUD just applied into the middle of the uterine cavity at the level of the fundus without attachment
Intervention Type
Device
Intervention Name(s)
IUD
Intervention Description
IUD insertion
Primary Outcome Measure Information:
Title
Expulsion rates
Description
IUD expulsion among the 3 groups at different intervals 24hours, 6 weeks, 3 and 6months postpartum
Time Frame
6months
Secondary Outcome Measure Information:
Title
Temperature
Description
postpartum fever (38 degrees celsius or above)
Time Frame
24 hours
Title
Irregular bleeding
Description
defined as irregular bleeding and menorrhagia discovered at 6 weeks, 3 and 6months postpartum
Time Frame
6 months.
Title
Vaginitis
Description
Defined as smelly odor, discharge diagnosed at 6 weeks, 3 and 6months postpartum
Time Frame
6 months
Title
postpartum hemorrhage
Description
Defined as heavy bleeding after delivery diagnosed in the first 24 hours after labor
Time Frame
24 hours

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
22 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Full term patients (≥ 37 weeks gestation). Singleton pregnancy. Elective cesarean section for an uncomplicated pregnancy. Healthy uterine cavity (no fibroid and no congenital anomaly) (Previously documented by history taking and/or ultrasound before pregnancy, and to be re-confirmed intraoperative). Exclusion Criteria: Preterm labor. Uterine fibroid distorting uterine cavity. History suggestive of previous pelvic inflammatory disease (Fever due to vaginal infection, ovarian abscess, repeated offensive vaginal infection, hydro/pyo-salpinx) 2 Rupture of membrane more than 12 hours. Multi-fetal pregnancy Placenta previa. Previous uterine surgery other than CS Documented congenital uterine anomalies intraoperative. History of IUD insertion before this pregnancy with side effects like "bleeding, ectopic pregnancy, expulsion, pelvic inflammatory disease" Uterine atony after delivery.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ahmed Kamel, M.D.
Phone
00201120022332
Email
dr.ahmed.m.kamel@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Mahmoud Soliman, M.D.
Phone
00201002166159
Email
dr_mahmoudsoliman@yahoo.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mamoud Soliman, M.D.
Organizational Affiliation
Lecturer of obstetrics and gynecology
Official's Role
Principal Investigator
Facility Information:
Facility Name
obstetrics and gynecology department, Kasr Alainy hospital
City
Cairo
ZIP/Postal Code
11562
Country
Egypt
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ahmed Kamel, M.D.
Email
dr.ahmed.m.kamel@gamil.com
First Name & Middle Initial & Last Name & Degree
mahmoud Soliman, M.D.
Phone
00201002166159
Email
dr_mahmoudsoliman@yahoo.com

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
25143756
Citation
Goldstuck ND, Wildemeersch D. Role of uterine forces in intrauterine device embedment, perforation, and expulsion. Int J Womens Health. 2014 Aug 7;6:735-44. doi: 10.2147/IJWH.S63167. eCollection 2014.
Results Reference
background
PubMed Identifier
20966692
Citation
Chen BA, Reeves MF, Hayes JL, Hohmann HL, Perriera LK, Creinin MD. Postplacental or delayed insertion of the levonorgestrel intrauterine device after vaginal delivery: a randomized controlled trial. Obstet Gynecol. 2010 Nov;116(5):1079-87. doi: 10.1097/AOG.0b013e3181f73fac.
Results Reference
background
Citation
Tjahjanto H, Haryuni IT. Hang-up IUD, new technique for suturing CuT-380A IUD to uterine fundus in immediate postplacental insertion during cesarean delivery: twelve months follow up. Indones J Obstet Ginecol. 2014;2-31:132-139.
Results Reference
background

Learn more about this trial

Comparing Expulsion Rates for Different Intrauterine Device Insertion Techniques

We'll reach out to this number within 24 hrs